Skip to main content

Bode John B

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Bode John B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

ZVRA Zevra Therapeutics, Inc.

Director5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 20, 2025 (view filing)Aug 191 dayBode John BDirectorPPurchase+5.00K$9.17+$45.9K+12.5%45.0K after
Mar 21, 2025 (view filing)Mar 192 daysBode John BDirectorPPurchase+10.0K$7.96+$79.6K+33.3%40.0K after
Jul 15, 2024 (view filing)Jul 123 daysBode John BDirectorPPurchase+10.0K$5.87+$58.7K+50.0%30.0K after
Sep 6, 2023 (view filing)Sep 51 dayBode John BDirectorPPurchase+10.0K$5.13+$51.3K+100.0%20.0K after
May 19, 2023 (view filing)May 181 dayBode John BDirectorPPurchase+10.0K$5.04+$50.4KNew position10.0K after6 lots